14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0320 $0.0579 Thursday, 2nd May 2024 GMDA stock ended at $0.0327. During the day the stock fluctuated 0% from a day low at $0.0327 to a day high of $0.0327.
90 days $0.0303 $0.431
52 weeks $0.0303 $2.51

Historical Gamida Cell Ltd. prices

Date Open High Low Close Volume
May 02, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
May 01, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 30, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 29, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 26, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 25, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 24, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 23, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 22, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 19, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 18, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 17, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 16, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 15, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 12, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 11, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 10, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 09, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 08, 2024 $0.0327 $0.0327 $0.0327 $0.0327 0
Apr 05, 2024 $0.0395 $0.0395 $0.0320 $0.0327 19 048 523
Apr 04, 2024 $0.0400 $0.0435 $0.0370 $0.0400 18 403 749
Apr 03, 2024 $0.0413 $0.0436 $0.0368 $0.0400 30 245 362
Apr 02, 2024 $0.0376 $0.0579 $0.0350 $0.0440 95 537 600
Apr 01, 2024 $0.0358 $0.0381 $0.0303 $0.0373 42 945 662
Mar 28, 2024 $0.0466 $0.0492 $0.0346 $0.0361 86 393 038
Click to get the best stock tips daily for free!

About Gamida Cell Ltd.

Gamida Cell Ltd. Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based can... GMDA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT